Tamsulosin Hydrochloride
Product Images NDC 42254-012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 42254-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1ceb560b 1a62 408d 8e30 23113e8c9dd3 01)

FDA Label Image

Figure1 (1ceb560b 1a62 408d 8e30 23113e8c9dd3 02)

FDA Label Image

Figure 2a (1ceb560b 1a62 408d 8e30 23113e8c9dd3 03)

Figure 2a (1ceb560b 1a62 408d 8e30 23113e8c9dd3 03)
This appears to be a table showing the mean change in a certain variable for different treatments and durations of treatment. The variable is not clear from the available text. The treatments listed are L, A, and placebo, with varying dosages indicated in milligrams. The duration of treatment ranges from 7 to 13 weeks. Without further information, it is not possible to provide more detail about the context or purpose of this table.*
FDA Label Image

Figure 2b (1ceb560b 1a62 408d 8e30 23113e8c9dd3 04)

Figure 2b (1ceb560b 1a62 408d 8e30 23113e8c9dd3 04)
The text provides a chart showing the mean change in treatment duration with different dosages of medication and a placebo. The duration of treatment is measured in weeks. There is no other information available to provide a useful description.*
FDA Label Image

Figure3a (1ceb560b 1a62 408d 8e30 23113e8c9dd3 05)

Figure3a (1ceb560b 1a62 408d 8e30 23113e8c9dd3 05)
This seems to be a table related to a medical study, evaluating the effects of a specific treatment compared to the placebo. The study measured a parameter referred to as "mL/sec" and lasted for 13 weeks, with data reported for each week. There were a variable number of participants at each timepoint, ranging from 617 to 755. No information is given regarding the nature of the treatment, the condition being treated, or the results of the study.*
FDA Label Image

Figure3b (1ceb560b 1a62 408d 8e30 23113e8c9dd3 06)

FDA Label Image

Tamsulosin HCl 0.4mg (1ceb560b 1a62 408d 8e30 23113e8c9dd3 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.